Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Nissan Formula E Team is looking for a solid start to the 2025/26 ABB FIA Formula E World Championship in São Paulo, Brazil, having completed a successful week of Pre-Season Testing in Valencia in October.  The event will mark Formula E’s fourth visit to Brazil, competing on the Anhembi Sambadrome, with the main straight situated […] The post Nissan Formula E Team to launch Season 12 charge in São Paulo appeared first on Web-Release.